Cargando…

The Patient-Reported Experience Measure for Improving qUality of care in Mental health (PREMIUM) project in France: study protocol for the development and implementation strategy

BACKGROUND: Measuring the quality and performance of health care is a major challenge in improving the efficiency of a health system. Patient experience is one important measure of the quality of health care, and the use of patient-reported experience measures (PREMs) is recommended. The aims of thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernandes, Sara, Fond, Guillaume, Zendjidjian, Xavier, Michel, Pierre, Baumstarck, Karine, Lancon, Christophe, Berna, Fabrice, Schurhoff, Franck, Aouizerate, Bruno, Henry, Chantal, Etain, Bruno, Samalin, Ludovic, Leboyer, Marion, Llorca, Pierre-Michel, Coldefy, Magali, Auquier, Pascal, Boyer, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345324/ https://www.ncbi.nlm.nih.gov/pubmed/30718945 http://dx.doi.org/10.2147/PPA.S172100

Ejemplares similares

Measuring the Patient Experience of Mental Health Care: A Systematic and Critical Review of Patient-Reported Experience Measures
por: Fernandes, Sara, et al.
Publicado: (2020)

Development and Calibration of the PREMIUM Item Bank for Measuring Respect and Dignity for Patients with Severe Mental Illness
por: Fernandes, Sara, et al.
Publicado: (2022)

A conceptual framework to develop a patient-reported experience measure of the quality of mental health care: a qualitative study of the PREMIUM project in France
por: Fernandes, S, et al.
Publicado: (2021)

Calibration and Validation of a PREMIUM-DT Item Bank to Measure the Experience of Drug Therapy for Patients with Severe Mental Illness
por: Fernandes, Sara, et al.
Publicado: (2022)

Disparities in suicide mortality trends between United States of America and 25 European countries: retrospective analysis of WHO mortality database
por: Fond, Guillaume, et al.
Publicado: (2016)

Psychometric properties of the Ruminative Response Scale-short form in a clinical sample of patients with major depressive disorder
por: Parola, Nathalie, et al.
Publicado: (2017)

Disparities in Intensive Care Unit Admission and Mortality Among Patients With Schizophrenia and COVID-19: A National Cohort Study
por: Fond, Guillaume, et al.
Publicado: (2020)

Mortalité dans la schizophrénie : vers un nouveau scandale sanitaire ? COVID-19 et schizophrénie
por: Fond, Guillaume, et al.
Publicado: (2021)

End of life breast cancer care in women with severe mental illnesses
por: Fond, Guillaume, et al.
Publicado: (2021)

Satisfaction of hospitalized psychiatry patients: why should clinicians care?
por: Zendjidjian, Xavier-Yves, et al.
Publicado: (2014)

Pregnancy, delivery and neonatal complications in women with schizophrenia: a national population-based cohort study
por: FABRE, Cyprien, et al.
Publicado: (2021)

The Validity of the SQoL-18 in Patients with Bipolar and Depressive Disorders: A Psychometric Study from the PREMIUM Project
por: Boyer, Laurent, et al.
Publicado: (2022)

Reducing Health Inequalities in Individuals with Severe Mental Disorders: Harnessing Real-World Data and Patient-Reported Measures
por: Boyer, Laurent, et al.
Publicado: (2023)

Impact of the COVID-19 pandemic on non-COVID-19 hospital mortality in patients with schizophrenia: a nationwide population-based cohort study
por: Boyer, Laurent, et al.
Publicado: (2022)

Psychometric properties of the abbreviated version of the Scale to Assess Unawareness in Mental Disorder in schizophrenia
por: Michel, Pierre, et al.
Publicado: (2013)

Measuring the Quality of Life in Patients with Multiple Sclerosis in Clinical Practice: A Necessary Challenge
por: Baumstarck, Karine, et al.
Publicado: (2013)

Computerized adaptive testing with decision regression trees: an alternative to item response theory for quality of life measurement in multiple sclerosis
por: Michel, Pierre, et al.
Publicado: (2018)

Clinical potential of lurasidone in the management of schizophrenia
por: Samalin, Ludovic, et al.
Publicado: (2011)

Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable Antipsychotics
por: Samalin, Ludovic, et al.
Publicado: (2016)

A Bayesian framework systematic review and meta-analysis of anesthetic agents effectiveness/tolerability profile in electroconvulsive therapy for major depression
por: Fond, Guillaume, et al.
Publicado: (2016)

Poverty and inequality in real-world schizophrenia: a national study
por: Fond, Guillaume B., et al.
Publicado: (2023)

A Multidimensional Computerized Adaptive Short-Form Quality of Life Questionnaire Developed and Validated for Multiple Sclerosis: The MusiQoL-MCAT
por: Michel, Pierre, et al.
Publicado: (2016)

Exploratory analysis of the French version of the beliefs about medicines questionnaire in patients with severe mental disorders: Factorial structure and reliability in specific populations of schizophrenic, bipolar and depressive patients
por: Samalin, Ludovic, et al.
Publicado: (2017)

Microbiota-Orientated Treatments for Major Depression and Schizophrenia
por: Fond, Guillaume B., et al.
Publicado: (2020)

Use of artificial nutrition near the end of life: Results from a French national population‐based study of hospitalized cancer patients
por: Baumstarck, Karine, et al.
Publicado: (2019)

Toward Meeting the Needs of Homeless People with Schizophrenia: The Validity of Quality of Life Measurement
por: Auquier, Pascal, et al.
Publicado: (2013)

C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review
por: Fond, Guillaume, et al.
Publicado: (2018)

Development of the PREMIUM Computerized Adaptive Testing for Measuring the Quality of Information Delivered to Patients with Severe Mental Illnesses
por: Boyer, Laurent, et al.
Publicado: (2022)

Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness
por: Llorca, Pierre Michel, et al.
Publicado: (2013)

Occurrence of Side Effects in Treatment-Resistant Depression: Role of Clinical, Socio-Demographic and Environmental Characteristics
por: Levy, Anna, et al.
Publicado: (2021)

Early and very early‐onset schizophrenia compared with adult‐onset schizophrenia: French FACE‐SZ database
por: Coulon, Nathalie, et al.
Publicado: (2020)

Pharmacological treatment profiles in the FACE-BD cohort: Treatment description and complete data for bipolar subtypes
por: Brodeur, Sébastien, et al.
Publicado: (2021)

Immuno-metabolic profile of patients with psychotic disorders and metabolic syndrome. Results from the FACE-SZ cohort
por: Foiselle, Marianne, et al.
Publicado: (2022)

Rural-urban variation in incidence of psychosis in France: a prospective epidemiologic study in two contrasted catchment areas
por: Szöke, Andrei, et al.
Publicado: (2014)

Immune Signatures of Treatment-Resistant Schizophrenia: A FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) Study
por: Leboyer, Marion, et al.
Publicado: (2021)

Metabolic and psychiatric effects of acyl coenzyme A binding protein (ACBP)/diazepam binding inhibitor (DBI)
por: Joseph, Adrien, et al.
Publicado: (2020)

The Role of Inflammation in the Treatment of Schizophrenia
por: Fond, Guillaume, et al.
Publicado: (2020)

Relationship between childhood physical abuse and clinical severity of treatment-resistant depression in a geriatric population
por: Yrondi, Antoine, et al.
Publicado: (2021)

Glutamatergic and N-Acetylaspartate Metabolites in Bipolar Disorder: A Systematic Review and Meta-Analysis of Proton Magnetic Resonance Spectroscopy Studies
por: Chabert, Jonathan, et al.
Publicado: (2022)

Determinants of patient satisfaction with hospital health care in psychiatry: results based on the SATISPSY-22 questionnaire
por: Zendjidjian, Xavier Y, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_j8hud6gfvnr66h0ej1620sha99